Massachusetts Senate Bill 552 (Prior Session Legislation)

---

Spectrum: Moderate Partisan Bill (Democrat 5-1)
Status: Introduced on January 22 2019 - 25% progression, died in chamber
Action: 2020-02-18 - Accompanied a study order, see S2543
Text: Latest bill text (Introduced) [PDF]

For legislation to promote transparency in prescription drug prices. Financial Services.

To promote transparency in prescription drug prices

Sen. Nick Collins [D]	Rep. Carmine Gentile [D]	Sen. Michael Moore [D]	Sen. Rebecca Rausch [D]
Sen. Patrick O'Connor [R]	Sen. Eric Lesser [D]

Date	Chamber	Action
2020-02-18	Senate	Accompanied a study order, see S2543
2019-09-12	Joint	Hearing scheduled for 09/23/2019 from 11:00 AM-03:00 PM in Gardner Auditorium
2019-01-22	House	House concurred
2019-01-22	Senate	Referred to the Joint Committee on Financial Services

S706 (Similar To) 2020-07-23 - Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session
S715 (Similar To) 2020-07-23 - Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session
S1989 (Similar To) 2019-07-15 - Accompanied H2827
H2768 (Similar To) 2020-11-06 - Accompanied a study order, see H5103
H2627 (Similar To) 2020-11-02 - Accompanied a study order, see H5080
S1701 (Similar To) 2020-11-02 - Accompanied a study order, see H5080
H1167 (Similar To) 2020-06-22 - Reporting date extended to Thursday December 31, 2020, pending concurrence
S2543 (Replaced by) 2020-02-20 - Discharged to the committee on Senate Rules

Type	Source
Summary	https://malegislature.gov/Bills/191/S552
Text	https://malegislature.gov/Bills/191/S552.pdf